drug · small molecule
tipifarnib
Phase 3updated 3mo agoby $KURA Kura Oncology, Inc.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 41 investigational indications.
targets
Protein farnesyltransferase
all catalysts(0)
nothing on the calendar yet
Trials studying tipifarnib
- phase2Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- —Expanded Access to Tipifarnib
- phase2Tipifarnib in Subjects With Myelodysplastic Syndromes
- phase2Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia
- phase2Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
- phase2Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy
- phase2Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy
- phase1Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 33m ago
Found something off?
comments(0)
5-min edit window · permanent after that